Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
PMA Graphene Technology Group Inc., listed on NASDAQ, announced that Mr. Zhijun Pan has resigned as CEO effective immediately due to personal commitments. Mr. Lei Liu has been appointed as the new CEO. The company, based in Hong Kong, provides wet trades services and also operates graphene thermal management technology through a subsidiary.
Rocky Mountain Chocolate Factory announces a limited-edition Miso Caramel Apple in partnership with Miraculous Corp to introduce a unique sweet-savory flavor and leverage the popular Miraculous franchise. This initiative aims to attract new customers, enhance in-store experiences, and drive sales through innovative product offerings tied to a globa…
Critical Metals Corp reported significant advancements in its mine-to-metals strategy for the Tanbreez Rare Earth Project in Greenland. The company highlights a novel refinery process in Romania expected to produce ultra-high purity rare earth products and valuable silica by-products, potentially generating annual revenues between $1.8–2.2 billion.…
FG Nexus announces its Board has approved a strategic shift to acquire affordable housing communities and a $10 million investment in FG Communities, a privately held operator of manufactured housing communities. The company plans to directly acquire land-lease affordable housing properties, fund acquisitions via cash, debt, and equity, and intends…
DLH Holdings Corp. has secured a follow-on task order from the National Heart, Lung, and Blood Institute valued at up to $43.7 million over two and a half years. The contract builds upon DLH's prior work since 2018, focusing on AI operations and automation to enhance IT services, cybersecurity, and infrastructure for around 2,000 NHLBI employees an…
Liberty Defense announced a new commercial agreement to deploy its HEXWAVE AI-based concealed weapon detection systems at multiple U.S. logistics and manufacturing facilities starting in 2026. The deployment includes a financing option for commercial customers and aims to protect both employees and assets by detecting metallic and non-metallic thre…
Orchestra BioMed announced that its investigational AVIM Therapy for uncontrolled hypertension will be featured in two sessions at the HRX Live 2026 conference, including a roundtable focusing on their collaboration with Medtronic to advance development and commercialization. The sessions will highlight AVIM Therapy's potential to reduce blood pres…
Autonomix Medical, a Nasdaq-listed medical device company specializing in nerve-targeted treatments, announced the appointment of Sandra Cohen Kalter, former Vice President and Chief Regulatory Counsel at Medtronic, to its Board of Directors. Kalter brings over 40 years of expertise in MedTech leadership, regulatory strategy, clinical development, …
Oragenics announced that its Chief Medical Officer will present at the IPAC-RS 2026 Nasal Innovation Forum, highlighting the clinical development and intranasal delivery technology of ONP-002, a first-in-class neurosteroid candidate for concussion treatment. The ongoing Phase IIa trial in Australia and anticipated U.S. IND submission in Q4 2026 wer…
Antelope Enterprise Holdings Limited announced the closing of a $6 million offering of 8% convertible promissory notes to an accredited investor. The proceeds will support the company’s livestreaming e-commerce operations in China. The notes bear interest at 8% annually, are convertible into Class A shares at a discount to market price with ownersh…
Nuwellis, a medical technology company specializing in cardiorenal patient solutions, announced the hiring of Brian Johnson as Director of Quality and Regulatory Affairs. Johnson brings significant experience in medical device regulation and quality management, aimed at strengthening Nuwellis' capabilities in product development, commercialization,…
Amaze Holdings, Inc. announces a new mutual referral partnership with C2 Live Inc., enhancing revenue opportunities for both platforms' creator and audience ecosystems. This collaboration builds on a previous strategic investment to enable cross-promotion, expanding monetization and engagement across Amaze's 14 million creator storefronts and C2's …
Propanc Biopharma presents a comparative analysis positioning its lead candidate PRP as a complementary therapy to FDA-approved and investigational RAS inhibitors from Revolution Medicines and Erasca. PRP, a proenzyme combo, targets epithelial-mesenchymal transition (EMT), cancer stem cells, and tumor microenvironment remodeling, addressing resista…
CTW, a Tokyo-based game platform company trading on Nasdaq, announced that CFO Patrick Liu will participate in a virtual fireside chat hosted by Alliance Global Partners on September 23, 2026. The discussion will cover CTW's flagship platform G123.jp, licensed anime intellectual properties, browser-based gaming model economics, and efforts to expan…
Equillium, Inc., a biotechnology company focused on therapies for autoimmune and inflammatory disorders, announced its management team's participation in a fireside chat at Stifel's 2026 Virtual Immunology and Inflammation Forum. The event will provide investor engagement opportunities and a live webcast of the discussion.
KKR & Co. has been identified as the preferred bidder to acquire Portuguese packaging manufacturer Logoplaste, entering exclusive negotiations with the company’s owners after rival Apax Partners withdrew from the process. Ontario Teachers’ Pension Plan Board, which holds a 60% stake in Logoplaste, has been pursuing a sale with advisers. Binding off…
Optimi Health Corp., a pharmaceutical company specializing in regulated psychedelic drug products, announced plans to begin a Health Canada-authorized Phase 3 clinical trial in 2027 evaluating MDMA-assisted therapy for PTSD. The trial will enroll up to 100 participants, focusing on veterans and frontline workers. This follows Optimi's recent Phase …
European Commission President Ursula von der Leyen said she wants to open discussions for Canada to become the European Union's first 'associate member.' The proposed arrangement would create a 'common prosperity and economic space' covering manufacturing, technology, defence industry integration, the Arctic, AI, energy and critical minerals. Legal…
MAIA Biotechnology has dosed the first U.S. patient in the Phase 2 THIO-101 clinical trial evaluating its lead drug candidate, ateganosine, for third-line treatment of non-small cell lung cancer (NSCLC). This expansion follows FDA clearance and is funded by a $2.3 million NIH grant. Prior data shows promising survival outcomes, and the trial aims t…
BofA Securities' European IT Services Indicator moved back into broadly neutral territory in August, extending a recovery that began in June. Four of the indicator's six components improved, offset in part by softer EU services PMI readings and stable global IT services earnings sentiment. BofA notes a correlation between the indicator and organic …
Novo Nordisk announced on Wednesday a strategic collaboration with Anthropic to apply Anthropic’s advanced AI models to the pharmaceutical company’s drug discovery and R&D processes. The agreement will pair Anthropic’s frontier models and Claude Science with Novo Nordisk’s scientific teams to address complex research problems, enhance biological re…
Palladyne AI (PDYN) remains a speculative play but recent partnership announcements, successful swarm autonomy tests and heavy short interest create an asymmetric trade setup. Market cap sits near $280M while balance-sheet metrics show liquidity but ongoing cash burn. For nimble traders: enter $5.72, stop $4.70, target $9.00 over a mid-term 45 trad…
VivoSim Labs presented new clinical benchmark data for its NAMkind™ 3D human liver and intestinal platforms at EUROTOX 2026. The data demonstrate superior predictive ability for drug toxicity across small molecules and antibody-drug conjugates (ADCs), particularly in assessing liver and gastrointestinal safety. The technology helps pharmaceutical c…
Royal Philips announced that two of its collaborations, SYMPHONY and AI FORSchung, received prestigious ITEA Awards of Excellence 2026 for their advancements in AI-enabled healthcare technologies. SYMPHONY connects healthcare data and clinical workflows through interoperable ecosystems, supporting multiple diseases with FDA-cleared technology. AI F…
Stellantis announced it will showcase nine concept cars from eight of its brands along with over 60 vehicles at the Paris Motor Show in October 2026. This event underscores the company’s renewed ambition under its FaSTLAne 2030 strategic plan, featuring international premieres including electric and hybrid models from brands such as DS Automobiles,…
